Which hedge funds own BMY? BRISTOL-MYERS SQUIBB CO, Q2 2026 13F holders
Healthcare · Open on the interactive board
12 of the hedge funds tracked by WhaleCreep disclosed a position in BMY (BRISTOL-MYERS SQUIBB CO) in their Q2 2026 13F filings, worth $270.6m in total. The largest holder by portfolio weight is Kahn Brothers at 1.6% of its book. 2 exited: Bridgewater Associates, Renaissance Technologies LLC.
12tracked managers holding
0opened this quarter
2exited this quarter
Which hedge funds hold BMY? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Kahn Brothers | Q2 2026 | 1.6% | $10.0m | 174,152 | 2% | added |
| Miller Value Partners | Q2 2026 | 0.9% | $4.0m | 69,500 | 0% | held |
| Woodline Partners | Q2 2026 | 0.2% | $67.3m | 1,167,476 | 4% | added |
| Tweedy Browne | Q2 2026 | 0.2% | $2.2m | 37,570 | 44% | added |
| Brevan Howard Capital Management | Q2 2026 | 0.1% | $9.4m | 163,962 | -4% | reduced |
| Citadel Advisors | Q2 2026 | 0.1% | $90.6m | 1,572,329 | 5% | added |
| Millennium Management | Q2 2026 | 0.0% | $43.4m | 752,576 | -89% | reduced |
| Horizon Kinetics | Q2 2026 | 0.0% | $2.6m | 44,552 | -0% | held |
| Ancora Advisors | Q2 2026 | 0.0% | $1.2m | 24,068 | -14% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $32.2m | 559,407 | 81% | added |
| First Manhattan | Q2 2026 | 0.0% | $6.8m | 118,863 | -5% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $874.0k | 15,169 | -100% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Bridgewater Associates | 2.2% | $14.7m |
| Renaissance Technologies LLC | 1.1% | $59.3m |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| Boston Omaha | Q4 2024 | 0.0% |
How has hedge fund ownership of BMY changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 12 | $270.6m |
| Q1 2026 | 15 | $942.8m |
| Q4 2025 | 12 | $407.3m |
| Q3 2025 | 11 | $319.9m |
| Q2 2025 | 10 | $369.3m |
| Q1 2025 | 9 | $400.2m |
| Q4 2024 | 16 | $602.1m |
| Q3 2024 | 13 | $338.1m |
| Q2 2024 | 11 | $207.7m |
| Q1 2024 | 11 | $147.5m |
| Q4 2023 | 11 | $290.7m |
| Q3 2023 | 12 | $257.2m |
| Q2 2023 | 13 | $237.6m |
| Q1 2023 | 13 | $215.9m |
| Q4 2022 | 15 | $231.2m |
| Q3 2022 | 10 | $167.7m |
Counts every tracked manager that disclosed BMY in that quarter's filing, including managers that have since stopped filing.